Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer

The aim of the present study was to determine the factors associated with reduced clinical benefits of personalized peptide vaccination (PPV) for pancreatic cancer. Phase II PPV clinical trials comprising 309 (8 non-advanced and 301 advanced-stage) patients with pancreatic cancer were conducted. Two...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Clin Oncol
Main Authors: Uchino, Yoshihiro, Muroya, Daisuke, Yoshitomi, Munehiro, Shichijo, Shigeki, Yamada, Akira, Sasada, Tetsuro, Yamada, Teppei, Okuda, Koji, Itoh, Kyogo, Yutani, Shigeru
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2021
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7788558/
https://ncbi.nlm.nih.gov/pubmed/33437477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2020.2201
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados